Israh Akhtar

Israh Akhtar, MD, is a Professor in the Department of Clinical Pathology and Laboratory Medicine at the Lewis Katz School of Medicine, Temple University. She serves as Director of the Cytopathology Fellowship, Director of Anatomical Pathology, and Director of Surgical Pathology, demonstrating leadership in both clinical and academic domains. Her work is centered at Temple University Hospital in Philadelphia, PA.

Education:

• MD, Medical School, University of Kashmir, Government Medical College, India
• Fellowship, Cytopathology, University of Mississippi Medical Center, Jackson, MS
• Residency, Anatomic and Clinical Pathology, Nassau University Medical Center, East Meadow, NY
• Residency, Pathology, Nassau University Medical Center, East Meadow, NY

Dr. Akhtar is board certified by the American Board of Pathology in Anatomic Pathology and Cytopathology. Her research and clinical interests focus on cytopathology, surgical pathology, diagnostic cytology, immunohistochemistry, and quality management in pathology. She has contributed extensively to the literature on fine-needle aspiration, rapid on-site evaluation (ROSE), and rare tumor diagnosis, particularly in head and neck, renal, and retroperitoneal pathologies.

Her recent publications (2017–2019) reflect a strong emphasis on diagnostic accuracy, cyto-histological correlation, and the application of molecular markers in cancer diagnosis. Themes include p16 immunostaining in oropharyngeal cancer, ROSE in spine lesions, and the role of cytology in lung metastases. These works highlight her expertise in integrating clinical, morphological, and molecular data for improved patient outcomes.

Dr. Akhtar has no listed scientific awards in the provided text.

She has mentored or collaborated with multiple researchers and clinicians, though no formal advisees or students are listed. Her work involves interdisciplinary collaboration, especially in improving clinician-pathologist communication and diagnostic workflows. She has not received any grants mentioned in the text.

Dr. Akhtar is involved in the Cytopathology Fellowship program, which she directs, indicating active participation in training the next generation of pathologists. Her work in quality management and diagnostic protocols suggests strong engagement with laboratory operations and patient safety initiatives.